Mobile

A multi-centre phase II controlled study of Vx-001 in Non Small Cell Lung Cancer (NSCLC)

Update Il y a 4 ans
Reference: EUCTR2006-005032-25

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To study the percentage of progression at six months of HLA-A*0201 positive vaccinated and HLA-A*0201 negative non vaccinated patients

Inclusion criteria

  • Patients with Non Small Cell Lung Cancer (NSCLC)

Links